Health & Happiness International (H&H, formerly Biostime International) has now launched its $350m dual-currency loan from Goldman Sachs into limited syndication.
Ingredient supplier Bayir Group has announced $2.45 million in funding which will be used for a manufacturing expansion primarily aimed at pharmaceutical applications.